Bank of America’s Beta Bionics BBNX Stock Holding History
Bought
Maintained
Sold
Other funds holding BBNX
EAM
SCM
SCV
FCM
VPC
RI
VCM
Bank of America's BBNX Position: Q1 2026 in Review
Bank of America reduced its Beta Bionics (BBNX) stake by 68% in Q1 2026, selling an estimated $4.38M and leaving 136,215 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4345.
Bank of America first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $13.2M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.
- Bank of America held 136,215 shares of Beta Bionics worth $1.36M as of Q1 2026.
- Bank of America sold 296,125 Beta Bionics shares in Q1 2026, an estimated $4.38M.
- Beta Bionics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4345 holding.
- Bank of America first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
- Bank of America's Beta Bionics position peaked at $13.2M in Q4 2025.
- 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.